Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

27.86
Delayed Data
As of Jun 24
 -1.43 / -4.88%
Today’s Change
26.97
Today|||52-Week Range
34.88
-17.94%
Year-to-Date
The Brexit Vote Is Crushing These 3 Clinical-Stage Biotech Stocks
Jun 24 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Leading In Pre-Market Activity
Jun 23 / TheStreet.com - Paid Partner Content
Post-Brexit Analysis: Should Investors Buy or Sell Biopharma?
Jun 24 / MotleyFool.com - Paid Partner Content
Voting Begin: Stocks Surge, Sterling Hits 2016 Highs, Futures Flirt With 2100
Jun 23 / Investing Channel - Paid Partner Content
Sanofi's Likely Sweetener for Medivation Panned
Jun 23 / TheStreet.com - Paid Partner Content
7 Pharmaceutical Stocks With Dividends Yielding More Than 3%
Jun 21 / MotleyFool.com - Paid Partner Content
AstraZeneca Likely to Grind Lower
Jun 23 / TheStreet.com - Paid Partner Content
This New Class Of Medicine Could Reshape Diabetes Treatment
Jun 20 / MotleyFool.com - Paid Partner Content
AstraZeneca, Teva Resolve Their Patent Row Over Diabetes Product
Jun 23 / TheStreet.com - Paid Partner Content
'Brexit': Stocks to Avoid on June 24
Jun 20 / TheStreet.com - Paid Partner Content
AstraZeneca Nasal Spray Flu Vaccine To be Hit By ACIP Vote
Jun 23 / Zacks.com - Paid Partner Content
Here's Why Novavax's Stock Could Double
Jun 14 / MotleyFool.com - Paid Partner Content